Skip to main content
Erschienen in: Journal of the International AIDS Society 3/2010

Open Access 01.11.2010 | Oral presentation

Homeostatic proliferation of memory T cells and expansion of the HIV-1 latent reservoir

verfasst von: A Bosque, V Planelles

Erschienen in: Journal of the International AIDS Society | Sonderheft 3/2010

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Background

Homeostatic proliferation is the ability of T cells to divide in the absence of activation. This process is mediated, preferentially, by the cytokine IL-7 and plays an important role in the long-term maintenance of immunological memory. Therefore, it is conceivable that the latent viral reservoir may be perpetuated or even expanded through homeostatic proliferation of memory T cells.

Methods

We have developed a system whereby naïve cells from the peripheral blood of healthy donors are induced to undergo normal development ex vivo in the presence of the appropriate cytokine cocktails and antigenic stimulation through CD3/CD28. These cells are infected while in the activated state, and return to quiescence as central memory cells (TCM). Infection of these ex-vivo-generated memory cells leads to latency with a high frequency and results in the formation of a polyclonal population of integrated viruses. Using this paradigm, we have explored the influence of homeostatic proliferation of TCM on HIV-1 latency.

Results

We have examined the influence of cell cycle on viral reactivation entry and found that memory lymphocytes harbouring latent proviruses are perfectly capable of cell division in the absence of viral reactivation when incubated in the presence of IL-2+IL-7. On the other hand, we have also observed that a combination of IL-2 and IL-7 induces inefficient viral reactivation (20% to 30% of that which is observed with antiCD3/antiCD28). While IL-2+IL-7 treatment induces inefficient reactivation, this cytokine cocktail triggers vigorous cellular proliferation. Our ex vivo model demonstrates that under these conditions, the net effect of IL-2+IL-7 treatment is an expansion, not a contraction, of the latent reservoir. We also examined the signalling pathway that leads to HIV-1 reactivation upon IL-2+IL-7 incubation. Our preliminary results indicate that reactivation by IL-2+IL-7 is both NFAT and NFκB independent.

Conclusions

Our results demonstrate that when latently infected NP cells are incubated with IL-7, cells proliferate in the absence of efficient HIV-1 reactivation. This concept has great relevance to therapy because of the implicit consequence that the latent reservoir may also be subject to homeostatic expansion. This mechanism could be contributing to the persistence of HIV-1 latency and should be taken into account when designing anti-latency treatments.

Acknowledgments

This work was supported by an AmFAR Mathilde Krim Fellowship to Alberto Bosque.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Metadaten
Titel
Homeostatic proliferation of memory T cells and expansion of the HIV-1 latent reservoir
verfasst von
A Bosque
V Planelles
Publikationsdatum
01.11.2010
Verlag
BioMed Central
Erschienen in
Journal of the International AIDS Society / Ausgabe Sonderheft 3/2010
Elektronische ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-13-S3-O6

Weitere Artikel der Sonderheft 3/2010

Journal of the International AIDS Society 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

23.04.2024 | Parkinson-Krankheit | Podcast | Nachrichten

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Professorin Dr. Claudia Trenkwalder, Neurologin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Nierenultraschall: Tipps vom Profi

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.